In vivo studies on the biochemical indices of Plasmodium berghei infected mice treated with Alstonia boonei leaf and root extracts.

BACKGROUND: A study on the biochemical indices of albino mice infected with Plasmodium berghei and treated with Alstonia boonei aqueous and ethanolic extracts was undertaken.
METHODS: 216 males mice were randomly assigned to six treatment groups each containing six mice for both aqueous and ethanolic extracts experiments. P. berghei NK-65 was inoculated into the mice intraperitoneally and establishment of infection confirmed. Administration of extracts of was done after phytochemical and acute toxicity tests at varying concentrations, for both suppressive and curative tests. Blood samples collected by ocular puncturing were examined for the biochemical indices; ALT, AST, ALP, creatinine and total protein using the standard procedures.
RESULTS: A. boonei extracts suppression of P. berghei in mice was comparable to the standard drug. Significantly higher (p<0.05) recovery of mice treated with A. boonei extracts was observed. The biochemical indices examined all had significantly (p<0.05) increased concentration after 7 days post-infection, except for total protein concentration which had no significant increase or decrease due to A. boonei extracts administration.
CONCLUSION: The antiplasmodial potentials of A. boonei leaf and root extracts were dosage and duration-dependent, and have demonstrated satisfactory normalization of altered biochemical indices due to malaria.

Background

Biochemical indices have been used as a reliable tool for the assessment of the health status of animals1. Some biochemical changes that have been reported to occur during malaria include cellular changes in energy metabolism, heme metabolism, membrane lipid peroxidation (LPO) and stress enzymes2. Changes in haematological indices (haemoglobin, white cell count, red cell count, mean cellular volume, reticulocyte count, and haemoglobin factor) have been associated with incidences of malaria3. Metabolic melee associated with electrolyte and fluid imbalance and changes in the biological functions of the liver are common complications of malaria and are dependent on the level of parasitemia4. Alterations in packed cell volume (PCV), random blood glucose (RBG), total bilirubin (TB), total proteins (TP), albumin, serum electrolytes sodium (Na+), potassium (K+), chloride (Cl−), bicarbonate (HCO3−), calcium (Ca2+), magnesium (Mg2+) and anion gap (AG) have been reported in children with malaria4. Malaria infections have been established to cause alterations in the plasma biochemical indices5. Studies have reported haematological and biochemical changes in malaria parasite-infected blood with common complications associated with this disease. Haematological changes that are associated with malaria infection include anaemia, thrombocytopenia and disseminated intravascular coagulation6. Changes in the physicochemical characteristic of Plasmodium-infected blood may vary with the degree of malaria endemicity, nutritional status, presence of haemoglobinopathies, demographic factors, and level of immunity to malaria6. Thus making haematological parameters essential biomarkers in the assessment of health status.

Furthermore, the infection of cells of the liver by malarial parasite sporozoites can cause cellular inflammation, organ congestion and sinusoidal blockage. These changes in hepatocytes can lead to the leakage of membranous (alkaline phosphatase) and parenchymal (transaminases) liver enzymes to the general body circulation. Hence increase in liver enzymes AST, ALT and ALP observed during malaria episodes also demonstrated that the serum activities of these liver function enzymes increased with the increase Plasmodium density. This change could confirm that the hepatic stage of the Plasmodium's life cycle in the animal host is accompanied by significant perturbation in the hepatocyte's parenchyma and membrane leading to leakage of liver enzymes into the general circulation6, thus making the assay of liver function enzymes a prerequisite in malaria diagnosis, treatment and management.

Malaria has been reported to be one of the factors responsible for acute renal failure in symptomatic patients in malaria-endemic areas7, and the adverse effect of Plasmodium on the kidney could lead to increase in blood urea, hypernatraemia, hyperkalaemia, low urine specific gravity, metabolic acidosis and a low ratio of urinary to blood urea7. The sudden increase in the urea level and imbalance in the level of the electrolyte such as sodium, potassium, bicarbonate and chloride in malaria-infected persons could serve as indicators for kidney dysfunction7 and as such critical factors to be managed during malaria episodes.

The cost of prevention of mosquito bites through the use of mosquito repellants or mosquitocides or treated mosquito nets is high for the inhabitants of malaria-endemic areas all over sub-Saharan Africa. Certain problems hamper malaria management, one of which is the resistance to the most widely available, affordable and safest first-line treatments such as chloroquine and fansider8. Secondly, malaria vectors demonstrate resistance to a wide range of insecticides, thereby making vector control strategies difficult. The third and rapidly developing problem is the widespread production of fake anti-malaria drugs and fourthly lack or inadequate infrastructure and resources to manage and control malaria spread and ward off fake curing agents9. Clinical trials on a large number of patients showed that artemisinin is effective in clearing parasitaemia and reducing symptoms in patients with malaria, including some with chloroquine-resistant malaria and cerebral malaria10. However, artemisinin has a side effect and its use as a monotherapy is not effective. There is a need to search for non-synthetic drugs as a substitute for artemisinin therapy.

Alstonia boonei is a large deciduous tree. It is widely distributed in Africa: Cameroon, Central African Republic, Ghana, Code d'Ivoire, Egypt and Nigeria11. The chemical, ethnomedicinal, pharmacological and toxicological properties of A. boonei has been studied and the result revealed that it is useful in the management and treatment of several illnesses11. The root bark is commonly used in Ghana along with other herbs in the management of arthritis12,13. The anti-inflammatory and antiarthritic properties of the root barks have been reported14,15. Furthermore, the antioxidant and antimicrobial properties of the stem bark have been documented16,17. Traditionally in Nigeria, the infusion of the stem bark is drunk as a remedy for snake-bite, and also for arrow poison17. It is also used for treating fever and the infusion of the root, stem bark and leaves are drunk as a remedy against asthma15. The efficacy of A. boonei oil extracts and derivatives as a potential botanical insecticide required for mosquito control has been demonstrated18. The blood schizontocidal activity of methanol root bark extracts of A. boonei against P. berghei infection in Swiss albino mice showed a significant anti-malaria potency which could be exploited in the formulation of standard anti-malaria drug19. Studies on ethanolic leaf5, methanol root bark19, aqueous leaf23, methanol stem and leaf30, and lime leaf36 extracts of A. boonei and its effect on some haematological and biochemical parameters of albino mice infected with P. berghei have been conducted. None of the studies utilized aqueous and ethanolic leaf and root extract of A. boonei. The present work evaluated in vivo the anti-Plasmodium and biochemical effects of A. boonei root and leaf ethanolic extracts in P. berghei infected albino mice. The root and leaf of the plant were selected for extraction because of the reported rich phytochemical composition of this plant parts11–17.

Methods

Alstonia boonei extracts and artesunate

The plant leaves and roots were collected from Inyi in Enugu-Ezike (Igbo-Eze North Local Government Area) of Enugu State, Nigeria from the wild. The plant parts were identified and authenticated by a botanist at the Department of Plant Science and Biotechnology, University of Nigeria Nsukka, wherein the voucher specimens (PSBH 2017-141) were kept in their herbarium. Fresh leaves and roots of A. boonei were washed, sliced and air-dried separately at room temperature to a constant weight. Each of them was pulverized and 800 g of the leaves and roots fine powder obtained was divided into two. Half of the separate fine powders were percolated in 1400 ml of water and the other half in 70 % ethanol, for aqueous and ethanolic extracts, respectively. They were filtered after 72 hours and the filtrates evaporated to dryness using a temperature-regulated water bath preset at 40° C and the wet granules dried in a hot air oven at 60° for 1 hour. Thereafter, the dried granules were milled and screened through a 1.0 mm sieve to yield the dry powder extracts concentrates. These were labelled accordingly and stored in a refrigerator at 4°C before use. The ethanol and aqueous extracts of A. boonei re-suspended in 5 ml of distilled water corresponding to the dosages 200, 400 and 800 mg kg−1 b.wt. of mice and the standard antimalarial drug -artesunate (100 mg kg−1 b.wt. of mice) were administered by oral intubations. Distilled water (not Tween 80) was used because in Nigeria traditional medicine practitioners use water and alcohol infusion of A. boonei to cure various diseases16,17.

Acute toxicity (LD50) of Alstonia boonei extracts

Acute toxicity (LD50) of the aqueous and ethanol extracts of A. boonei leaves and roots were determined by Lorke's method20. Eighteen (18) adult albino mice were used for this experiment. The experiment was conducted in two phases. In the first phase, three groups of three mice each were orally administered 10, 100, 1000 mg/kg body weight of the extract, respectively and observed for 24 hours for some death and behavioural changes. In the second phase, based on the fact that no mortality was recorded (100 % survival rates), increased doses of 1500, 3000 and 6000 mg/kg body weight were orally administered to three additional mice for each group, respectively, and the fourth mice received only solvent (5% Tween 80) which served as the control. The mice administered with ethanol and aqueous extracts of A. boonei leaves and roots were observed for 24 hours and the number of deaths was recorded. The second experiment recorded no death even at 6000 mg/kg, thus the extract was regarded as safe. The least sub-lethal dosage used for this experiment was thirty times reduction of the highest safe dosage and subsequently doubled for increasing dosages.

Experimental animal

Two hundred and sixteen (216) male conventional grade UN-FERH: NS outbred strain of albino mice (Mus musculus) used in the study were procured from the Genetic and Breeding Laboratory of the Department of Zoology and Environmental Biology, University of Nigeria, Nsukka. The mice were maintained according to the National Research Council guidelines on laboratory animal use21. Furthermore, this experiment was designed following the Three R (replacement, reduction and refinement) alternatives ethic of animal experimentation22, with much emphasis on refinement as the experimental procedures adopted minimized pain, distress, and enhanced the welfare of mice used in this study. Food and water were available ad libitum.

Plasmodium berghei

The artesunate-sensitive strain of the rodent parasite Plasmodium berghei NK-65 was obtained from our institution Veterinary Teaching Hospital. The strain was maintained in the laboratory for the period of the study by in vivo serial blood passage from mouse to mouse23. A set of mice parasitized with P. berghei NK-65 were anaesthetized after 6 days having shown clinical symptoms of malaria and confirmed microscopically (>2 × 107 P. berghei parasitized erythrocytes). Samples of blood were collected by cardiac puncture using a sterile needle and syringe. The samples were diluted in normal saline (1 ml of blood in 10 ml of normal saline), and 0.2 ml of blood containing 1 × 107 P. berghei infected erythrocytes was used to infect each of the experimental mice intraperitoneally19.

Study design and anti-plasmodial effects of plant extracts

This study adopted a completely randomized design. Six treatment groups containing six mice each in three replicates for each extract was used in the present study. Group I: Baseline, mice not infected and not treated; Group II: Control, infected and not treated; Group III: Artesunate, infected and treated with the standard drug (artesunate, 100 mg/kg body wt/day); Groups IV, V and VI: 400, 600 and 800 mg/kg body wt/day, infected and treated with 400, 600 and 800 mg/kg/day of extract. Three mice from each group were used for the suppressive test (treated 4 hours after parasite inoculation for 4 days). The remaining mice were used for the curative test (treated 72 hours after parasite inoculation for 4 days) as well as for biochemical examination. At the end of the experiment, their mean survival times (MST) were estimated24.

MST = Number of days survived / Total Number of days (28) × 100

Blood sampling and assay

Mice were anaesthetized by chloroform inhalation in the air-tight chamber. Blood samples (5 ml) collections were made at both tail and ocular regions at three periods (24 hours before parasite inoculation; 72 hours after parasite inoculation; and 24 hours after overall treatment for 4 days). Blood samples were collected from the tail of each mouse to make thin blood smear following standard procedure, and parasitaemia levels were determined microscopically25. From the parasitaemia level, percentage parasitaemia and suppression were deduced25,26.

% Parasitaemia = Total number of parasitized erythrocytes x 100 / Total number of erythrocytes

% Suppression = Parasitaemia in the control group - Parasitaemia in study group × 100 / Parasitaemia in the control group

Also, pooled mouse blood samples collections by ocular puncturing were dispensed into plain bottles for biochemical examinations using the methods of Sood27. Samples in plain bottles were centrifuged at 3000 rpm for 10 minutes at room temperature, and biochemical indices of ALT, AST, ALP, creatinine, and total protein were estimated using Randox Diagnostic Kits as described by Reitman and Frankel28, except for total protein and creatinine that were estimated using the methods of Bradford29. At the end of the experiment, mice were humanely sacrificed under anaesthesia and dead mice incinerated.

Statistical analysis

Data were analyzed using SPSS version 20. Analysis of Variance (ANOVA) and Duncan's multiple new range test was used to compare the mean differences among extracts concentrations. Mean difference of p<0.05 was regarded as significant.

Results

Alstonia boonei extracts did not affect the MST of mice

The comparative survival time of infected mice 28 days post-infection with P. berghei and treated with aqueous and ethanolic leaf and root extracts of A. boonei had statistically similar (p>0.05) survival time with those treated with the standard drug (Figure 1). Mean survival for the mice infected with P. berghei and treated with extracts as well as the standard drug was significantly higher than the MST of infected and untreated mice (p<0.05).

Figure 1

Mean survival time of mice infected with P. berghei and treated with leaf and root extracts of A. boonei (curative). Mean values with different alphabets as superscripts are significantly different (p<0.05)

Alstonia boonei extracts suppressed parasitaemia

The percentage parasitaemia and suppression of parasitaemia in P. berghei infected mice when treated with aqueous and ethanolic leaf and root extracts of A. boonei are summarized in Tables 1 – 2. The percentage of parasitaemia and parasitaemia suppression for the duration of treatment is presented for both the suppressive and curative tests. Table 1 showed the percentage parasitaemia and average percentage reduction of parasitaemia when treatment was commenced 4 hours post-infection for the suppressive test. The aqueous leaf, ethanolic leaf and ethanolic root extracts at concentration 400, 600 and 800 mg/kg body wt/day had similar parasitaemia suppressive ability comparable to the standard drug (Table 1). This suppressive ability was concentration-dependent, increasing as concentration increases. For the curative test, the percentage parasitaemia and suppression of A. boonei extracts on mice infected with P. berghei were represented in Table 2. Table 2 showed percentage parasitaemia in mice infected with P. berghei at the end of day 4 treatments, with either standard drug or root and leaf extracts of A. boonei, and the parasitaemia suppressive effect of the extracts or standard drug at the end of day 4 treatments. The percentage parasitaemia was significantly (p<0.05) less in the groups administered 400, 600 and 800 mg/kg body wt/day concentrations of A. boonei extracts compared to the Control group, and the percentage suppression of parasitaemia in the same groups administered aqueous leaf, ethanolic leaf and root extracts of A. boonei was comparable to the standard drug after day 4 treatment.

Table 1

Percentage parasitaemia and chemosuppressive activities of aqueous and ethanolic leaf and root extracts of A. boonie in P. berghei infected mice (suppressive test)

Treatments	Parasitaemia (%)	Chemosuppressive activities
Baseline	0.00 ± 0.00a1	0.00 ± 0.00a1
Control	2.12 ± 6.41b7	0.00 ± 0.00a1
Artesunate	6.87 ± 1.53a2	67.67 ± 7.42b5
Aqueous leaf (400 mg/kg)	9.57 ± 2.03a4	54.66 ± 9.62b4
Aqueous leaf (600 mg/kg)	9.10 ± 2.00a4	57.00 ± 9.50b4
Aqueous leaf (800 mg/kg)	7.00 ± 1.75a3	66.33 ± 7.69b5
Aqueous Root (400 mg/kg)	31.17 ± 5.73a2	39.33 ±11.14b3
Aqueous Root (600 mg/kg)	22.57 ± 7.95a8	56.00 ± 15.31b4
Aqueous root (800 mg/kg)	15.00 ± 3.05a6	71.00 ± 5.51b6
Ethanolic leaf (400 mg/kg)	7.53 ± 2.41a3	86.33 ± 4.49b7
Ethanolic leaf (600 mg/kg)	6.67 ± 1.76a2	88.00 ± 3.22b7
Ethanolic leaf (800 mg/kg)	6.60 ± 2.44a2	88.33 ± 4.26b7
Ethanolic Root (400 mg/kg)	12.60 ± 3.81a5	77.33 ± 7.77b6
Ethanolic Root (600 mg/kg)	12.23 ± 1.19a5	78.00 ± 2.31b6
Ethanolic root (800 mg/kg)	7.87 ± 2.67a3	86.00 ± 4.58b7

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among treatment indices. Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extracts.

Table 2

Percentage parasitaemia and chemosuppresion of P. berghei in infected mice at day 4 post treatment with aqueous and ethanolic leaf and root extracts of Alstonia boonei (curative test)

Treatments (mg/Kg b. wt/day)	Parasitaemia (%)	Chemosuppressive activities
Baseline	0.00 ± 0.00a1	0.00 ± 0.00a1
Control	6.53 ± 8.43b13	0.00 ± 0.00a1
Artesunate	7.00 ± 0.58a2	88.33 ± 1.76b4
Aqueous leaf (400 mg/kg)	12.00 ± 1.73a6	81.67 ± 2.60b4
Aqueous leaf (600 mg/kg)	9.33 ± 1.86a4	85.66 ± 2.85b4
Aqueous leaf (800 mg/kg)	8.17 ± 1.01a3	87.66 ± 1.45b4
Aqueous Root (400 mg/kg)	24.00 ± 2.08a12	64.73 ± 2.99b2
Aqueous Root (600 mg/kg)	21.33 ± 4.18a11	66.40 ± 3.82b2
Aqueous root (800 mg/kg)	14.03 ± 2.31a7	73.00 ± 2.52b3
Ethanolic leaf (400 mg/kg)	12.93 ± 2.30a6	79.67 ± 3.53b2
Ethanolic leaf (600 mg/kg)	11.50 ± 3.33a5	87.33 ± 1.20b4
Ethanolic leaf (800 mg/kg)	7.67 ± 1.96a2	88.00 ± 3.06b4
Ethanolic Root (400 mg/kg)	19.60 ± 1.93a10	76.33 ± 2.33b3
Ethanolic Root (600 mg/kg)	18.43 ± 0.81a9	77.66 ± 0.88b3
Ethanolic root (800 mg/kg)	15.33 ± 1.20a8	81.67 ± 1.20b4

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among treatment indices. Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extracts.

Alstonia boonei altered biochemical indices

The effects of the aqueous and ethanolic leaf and root extracts of A. boonei in P. berghei infected mice biochemical indices are summarized in Tables 3 – 7. The biochemical indices of alanine aminotransferase, aspartate aminotransferase, and creatinine of mice infected with P. berghei between 4 and 7 days treatment with extracts normalized the post-infection significantly (p<0.05) and insignificantly (p≥0.05) increases and alterations in the concentrations, which is comparable to the Artesunate (Tables 3 – 5). From the results, the parameters of alkaline phosphatase and total protein as observed after aqueous and ethanolic leaf and root extracts of A. boonei was administered demonstrated an insignificantly (p≥0.05) inconsistent alterations (Tables 6 and 7). The extract effects compared well to the Artesunate for the same duration of treatment.

Table 3

Effects of aqueous and ethanolic leaf and root extracts of Alstonia boonei treatments on alanine aminotransferase of P. berghei infected mice

Treatments(mg/Kg b. wt/day)	ALT (I/U)
	BI	AI	AT
Baseline	23.00±0.87a5	23.00±0.87a1	22.17±0.88a2
Control	23.00±0.58a5	26.83±1.09a4	38.07±0.12b6
Artesunate	20.50±0.29a2	27.00±0.00b5	26.93±1.59b5
Aqueous leaf (400 mg/kg)	21.00±0.58a3	25.30±0.66b3	21.93±0.48a1
Aqueous leaf (600 mg/kg)	21.67±0.88a3	27.00±0.87b5	22.40±0.45a2
Aqueous leaf (800 mg/kg)	21.00±0.00a3	24.00±0.70c2	23.70±0.46b3
Aqueous Root (400 mg/kg)	20.83±0.60a2	26.03±0.55c2	21.73±1.17b1
Aqueous Root (600 mg/kg)	23.63±1.68b5	26.83±1.42c4	21.90±1.40a1
Aqueous root (800 mg/kg)	22.00±1.16a4	25.33±0.83c3	23.90±1.43b3
Ethanolic leaf (400 mg/kg)	19.67±0.67a1	27.86±0.94c5	24.50±0.40b4
Ethanolic leaf (600 mg/kg)	22.20±1.11a4	24.56±0.56c2	23.53±1.35b3
Ethanolic leaf (800 mg/kg)	19.00±0.58a1	26.07±0.48c4	23.80±0.25b3
Ethanolic Root (400 mg/kg)	22.00±0.00a4	25.17±0.73c3	24.23±0.29b4
Ethanolic Root (600 mg/kg)	22.33±1.20a4	25.90±0.08c3	24.57±1.11b4
Ethanolic root (800 mg/kg)	21.67±0.88a3	25.67±1.20c3	22.30±0.35b2

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among different treatment periods. Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extract. BI: Before Inoculation; AI: After Inoculation; AT: After Treatment.

Table 7

Effects of aqueous and ethanolic leaf and root extracts of Alstonia boonei treatments on total protein of P. berghei infected mice

Treatments(mg/Kg b. wt/day)	Total Protein (g/dl)
	BI	AI	AT
Baseline	4.80 ± 0.06b5	4.53 ± 0.12a2	4.80 ± 0.06b1
Control	4.83 ± 0.15b5	4.43 ± 0.07a2	7.17 ± 0.09c4
Artesunate	4.70 ± 0.06b4	4.50 ± 0.06a2	4.73 ± 0.09b1
Aqueous leaf (400 mg/kg)	4.60 ± 0.06b3	4.43 ± 0.07a2	4.90 ± 0.06c1
Aqueous leaf (600 mg/kg)	4.70 ± 0.05b4	4.07 ± 0.33a2	4.87 ± 0.09c2
Aqueous leaf (800 mg/kg)	4.70 ± 0.06b4	4.20 ± 0.00a2	4.80 ± 0.06c1
Aqueous Root (400 mg/kg)	4.43 ± 0.09b1	3.70 ± 0.00a1	5.30 ± 0.06c2
Aqueous Root (600 mg/kg)	4.53 ± 0.12b2	3.50 ± 0.15a1	5.27 ± 0.09c2
Aqueous root (800 mg/kg)	4.53 ± 0.20b2	3.67 ± 0.12a1	4.53 ± 0.12b1
Ethanolic leaf (400 mg/kg)	4.46 ± 0.03b1	3.77 ± 0.09a1	5.63 ± 0.33c2
Ethanolic leaf (600 mg/kg)	4.45 ± 0.06b1	3.70 ± 0.15a1	5.60 ± 051c3
Ethanolic leaf (800 mg/kg)	4.46 ± 0.00b1	3.70 ± 0.21a1	4.47 ± 0.12b1
Ethanolic Root (400 mg/kg)	4.70 ± 0.06b4	4.00 ± 0.00a2	5.10 ± 0.06c2
Ethanolic Root (600 mg/kg)	4.97 ± 0.07b6	4.23 ± 0.09a2	4.90 ± 0.06b1
Ethanolic root (800 mg/kg)	4.77 ± 0.38c4	4.20 ± 0.10a2	4.67 ± 0.09b1

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among different treatment periods. Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extract. BI: Before Inoculation; AI: After Inoculation; AT: After Treatment.

Table 5

Effects of aqueous and ethanolic leaf and root extracts of Alstonia boonei treatments on creatinine level of P. berghei infected mice

Treatments(mg/Kg b. wt/day)	Creatinine (mg/dl)
	BI	AI	AT
Baseline	0.73 ± 0.88b2	0.63 ± 0.09a1	0.73 ± 0.09b1
Control	0.67 ± 0.88a1	2.03 ± 0.34b3	3.03 ± 0.03c3
Artesunate	0.77 ± 0.12a2	2.27 ± 0.29b3	0.73 ± 0.03a1
Aqueous leaf (400 mg/kg)	0.80 ± 0.06a3	1.83 ± 0.12b2	1.30 ± 0.17b2
Aqueous leaf (600 mg/kg)	0.66 ± 0.07a1	2.17 ± 0.32c3	1.23 ± 0.15b12
Aqueous leaf (800 mg/kg)	0.83 ± 0.09a3	2.33 ± 0.29b3	0.80 ± 0.06a1
Aqueous Root (400 mg/kg)	0.73 ± 0.03a2	1.43 ± 0.34b2	1.06 ± 0.23b2
Aqueous Root (600 mg/kg)	0.63 ± 0.09a1	2.00 ± 0.12b3	0.77 ± 0.12a1
Aqueous root (800 mg/kg)	0.83 ± 0.09a3	1.87 ± 0.18b2	0.70 ± 0.15a1
Ethanolic leaf (400 mg/kg)	0.77 ± 0.03a2	2.00 ± 0.15b3	1.73 ± 0.12a2
Ethanolic leaf (600 mg/kg)	0.60 ± 0.06a1	2.23 ± 0.12c3	1.17 ± 0.09b2
Ethanolic leaf (800 mg/kg)	0.60 ± 0.00a1	2.20 ± 0.15c3	1.00 ± 0.58b2
Ethanolic Root (400 mg/kg)	0.67 ± 0.03a1	2.13 ± 0.17c3	1.00 ± 0.12b2
Ethanolic Root (600 mg/kg)	0.77 ± 0.09a2	2.30 ± 0.00b3	0.87 ± 0.09a1
Ethanolic root (800 mg/kg)	0.80 ± 0.06a3	2.20 ± 0.06b3	0.80 ± 0.06a1

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among different treatment periods.

Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extract. BI: Before Inoculation; AI: After Inoculation; AT: After Treatment.

Table 6

Effects of aqueous and ethanolic leaf and root extracts of Alstonia boonei treatments on alkaline phosphatase of P. berghei infected mice

Treatments(mg/Kg b. wt/day)	ALP (I/U)
	BI	AI	AT
Baseline	41.93 ± 0.98a11	42.97 ± 0.55a3	42.97 ± 0.55a4
Control	38.33 ± 2.40a9	44.33 ± 1.20b5	55.23 ± 1.61c6
Artesunate	40.33 ± 2.60a10	43.97 ± 0.55c4	42.97 ± 0.55b4
Aqueous leaf (400 mg/kg)	38.03 ± 1.16a9	44.33 ± 0.03c1	43.13 ± 0.65b5
Aqueous leaf (600 mg/kg)	36.30 ± 1.72a7	41.33 ± 0.88b2	43.30 ± 0.70c5
Aqueous leaf (800 mg/kg)	37.67 ± 2.33a8	43.67 ± 1.20c4	42.24 ± 1.28b4
Aqueous Root (400 mg/kg)	37.53 ± 351a8	40.66 ± 0.33b1	40.56 ± 4.96b1
Aqueous Root (600 mg/kg)	29.67 ± 3.84a1	40.33 ± 0.88b1	41.50 ± 1.18c3
Aqueous root (800 mg/kg)	34.00 ± 1.15a5	40.67 ± 0.67b1	42.43 ± 1.26c4
Ethanolic leaf (400 mg/kg)	31.77 ± 1.20a2	43.33 ± 0.88c4	37.00 ± 0.06b1
Ethanolic leaf (600 mg/kg)	32.67 ± 1.77a3	41.66 ± 1.20c2	37.03 ± 0.61b1
Ethanolic leaf (800 mg/kg)	31.07 ± 0.58a2	42.27 ± 0.69c3	39.47 ± 0.33b2
Ethanolic Root (400 mg/kg)	33.00 ± 1.53a4	42.33 ± 0.26c3	40.33 ± 1.33b2
Ethanolic Root (600 mg/kg)	35.00 ± 1.53a6	41.00 ± 0.58c2	40.90 ± 0.95b2
Ethanolic root (800 mg/kg)	32.00 ± 1.15a3	42.00 ± 0.58c3	41.93 ± 0.61b3

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among different treatment periods.

Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extract. BI: Before Inoculation; AI: After Inoculation; AT: After Treatment.

Discussion

Mean survival time of P. berghei infected mice

Mean survival is a statistic that refers to how long patients survive with a disease in general or after a certain treatment. In this study, P. berghei infected mice treated with aqueous and ethanolic leaf and root extracts of A. boonei had similar MST that was statistically different and higher than infected and untreated mice. This indicated that the aqueous and ethanolic leaf and root extracts of A. boonei, as well as the standard drug, were effective in suppressing the level of parasitemia in the infected mice. In a comparative study of genotoxicity and anti-plasmodial activities of stem and leaf extracts of A. boonei in malaria-infected mice, chloroquine had the highest MST followed by A. boonei stem extract30.

Alstonia boonei suppressed parasitaemia

Plasmodium berghei has been used in predicting treatment outcomes of any suspected anti-malaria agent because of its high sensitivity to malaria drug-like chloroquine, artesunate etc., thus making it the appropriate parasite for this study31, and has been used in studying the anti-malaria potentials in mice32. The suppressive test is a standardized test commonly used for anti-malaria screening. It is used for the determination of percentage inhibition of parasitaemia5. The result of this study indicated that the aqueous and ethanolic leaf and root extracts of A. boonei exhibited some activities against P. berghei, especially in ethanolic leaf extracts. The chemo-suppressive effect of the extracts occurred in a dose-dependent manner in the different extracts. The highest suppressive effect was observed with the standard drug (artesunate). However, the value was similar to that observed for extract dose of 800 mg/kg/day. In this study, the result of the curative effect of the plant extracts equally showed a concentration-dependent activity. The highest curative effect of the plant extracts was observed when the highest dose (800 mg/kg/body wt/day) was administered. This was consistent with the findings of Onwusonye and Uwakwe19 who also recorded the highest curative effect for the root bark of the plant extract when the same dose was administered. There were significant decreases in parasite density in the treated groups compared to the untreated group. The present finding agreed with the report of Matsuoka et al.33 that when a standard anti-malaril drug was used in mice infected with P. berghei, it suppressed the parasitaemia to a non-detectable level. The antimalarial activity of A. boonei aqueous and ethanolic leaf and root extracts could be attributed to the presence of some phytochemicals in the plant16. Both aqueous and ethanolic extracts had almost similar secondary metabolites except for the presence of saponins only in the ethanolic extract. General glycosides, flavonoids, terpenoids and steroids, and alkaloids were present in both aqueous and ethanolic leaf and root extracts of A. boonei, while carotenoids, coumarins, anthraquinones, anthraquinones glycosides and cyanogenetic glycosides were absent in both extracts34. Specifically, the parasitaemia suppression effect of the extract may be attributed to the presence of alkaloids35,36.

In this study, administration of A. boonei extracts and artesunate normalized the activities of aspartate aminotransferase and alanine aminotransferase enzymes found in various parts of the body. Elevated amounts of these enzymes in the blood may signal a health problem37. AST and ALT test is commonly used to check for liver disease, to monitor liver disorder, to ascertain treatment efficacy and to make sure that medications are not causing liver damage. After inoculation of P. berghei, there was a significant increase in AST of infected mice (Control group, Artesunate group and the groups treated with different concentration of extracts) when compared to the Baseline group. This is as a result of degeneration changes in the hepatocytes due to the infection by P. berghei that have altered the activity of enzymes. After treatment, it was observed that levels of AST and ALT were significantly higher (p<0.05) in the Control group when compared to the Artesunate group and the groups treated with extracts. This may be as a result of inducing the activity of the enzyme by the extracts and the standard drug and was consistent with the report of Momoh et al.5 that the AST and ALT values of Control group were higher due to the normality of the enzyme activity by the extracts. From the present study, there was a significant increase (p<0.05) in plasma creatinine as a result of damage caused by the continuous multiplication of the parasite when compared to Baseline groups, Artesunate group and the groups treated with different concentration of extracts. After inoculation, there was significant (p<0.05) increase in alanine phosphatase in the Control group, Artesunate group and the groups treated with different concentration of the extracts when compared to the Baseline in all the extracts except in aqueous leaves extract as a result of infection by the P. berghei. After treatment, ALP of the Control group had significantly (p<0.05) higher ALP when compared to the Baseline group, Artesunate group and the groups trated with different concentration of the extracts. This increase in ALP is associated with liver damage which was slightly normalized in the group treated with the extracts and the standard drug. This finding was in agreement with the reports of Momoh et al.5, Halim et al.38 and Momoh and Manuwa39 who reported that an increase in ALP level was as a result of liver damage. Total protein also is a biochemical test for measuring the total amount of protein in the serum. In this study, it was observed that after treatment, there was a decrease in the total protein level of the Control group when compared to other groups. This may be due to the reduction in protein synthesis. Since malaria destroys cells that are responsible for protein synthesis, these findings agreed with an earlier report that chronic infections are autoimmune diseases that reduced protein synthesis40.

Furthermore, the findings of this study were in agreement with the finding of studies on therapeutic potentials, chemopreventive and remediation effect of Adansonia digitata stem bark extracts in rodent malaria41,42. They reported that A. digitata stem back aqueous and methanolic extracts showed a significant dose-dependent increase percentage chemosupression/clearance, PCV and a significant decrease in percentage parasitemia at the two doses administered after established infection41. Methanolic extract (400 mg/kg) exhibited the highest chemosupressive activity. The extract significantly reduced the degree of tissue peroxidation, increased the level of reduced glutathione (GSH), superoxide dismutase and catalase activity. Furthermore, the extracts reduced serum tumour necrosis factor-alpha (TNF-α) and C-reactive protein (CRP) concentrations and serum and tissue ALP activity42.

The normalization of liver enzyme activity in A. boonei extract-treated mice infected with P. berghei has been attributed to rich vitamin, mineral and phytochemical contents of A. boonei16. Considering the phytochemicals, flavonoids are potent water-soluble antioxidants and free radical scavengers that prevent oxidative cell damage, have high anticancer activity and also lower the risk of heart diseases43. Saponin neutralizes the effect of some harmful gut enzymes, build the immune system and promoting wound healing. Alkaloids have been linked to analgesic, antispasmodic and bactericidal activities, and tannins are reported to hasten the healing of wounds and inflamed mucous membrane44. Cardiac steroids have been linked to the treatment of congestive heart failure by increasing the force of heart contraction (positive inotropic activity) in patients with heart failure44. The presence of these phytochemicals in A. boonei supports its medicinal use.

Conclusion

The extracts potentials of A. boonei leaf and root were dependent on both dosage and duration, and have demonstrated satisfactory normalization efficacy to biochemical indices in malaria treatment.

Table 4

Effects of aqueous and ethanolic leaf and root extracts of Alstonia boonei treatments on aspartate aminotransferase of P. berghei infected mice

Treatments(mg/Kg b. wt/day)	AST (I/U)
	BI	AI	AT
Baseline	26.97 ± 0.55a3	26.97 ± 0.55a1	26.97 ± 0.55a2
Control	27.00 ± 0.58a4	35.67 ± 1.45b3	50.07 ± 0.58c3
Artesunate	25.23 ± 0.75a2	42.67 ± 0.33c6	27.37 ± 1.31b3
Aqueous leaf (400 mg/kg)	26.83 ± 1.92a3	44.00 ± 3.27c8	30.77 ± 0.15b5
Aqueous leaf (600 mg/kg)	27.30 ± 0.30a4	43.33 ± 3.71c7	29.33 ± 1.86b4
Aqueous leaf (800 mg/kg)	27.53 ± 0.82a4	38.67 ± 3.84b4	27.37 ± 1.31a3
Aqueous Root (400 mg/kg)	26.33 ± 1.20a3	41.33 ± 1.86c5	39.03 ± 0.58b7
Aqueous Root (600 mg/kg)	24.83 ± 0.73a1	47.00 ± 1.53c10	31.23 ± 1.74b6
Aqueous root (800 mg/kg)	25.70 ± 0.30a2	45.33 ± 0.33b9	25.93 ± 1.18a1
Ethanolic leaf (400 mg/kg)	26.00 ± 0.58a3	42.37 ± 1.44c2	29.00 ± 1.00b4
Ethanolic leaf (600 mg/kg)	26.00 ± 1.53a3	50.00 ± 0.00c12	29.00 ± 0.58b4
Ethanolic leaf (800 mg/kg)	26.07 ± 0.07a3	48.00 ± 2.00b11	26.33 ± 0.62a2
Ethanolic Root (400 mg/kg)	25.33 ± 0.33a2	34.67 ± 0.67c2	30.03 ± 0.55b5
Ethanolic Root (600 mg/kg)	28.00 ± 0.06a5	35.67 ± 0.33c3	29.37 ± 0.68b4
Ethanolic root (800 mg/kg)	26.10 ± 0.10a3	34.67 ± 1.20c2	29.16 ± 0.44b4

All values expressed as mean ± standard error of mean. Different superscript letters on the same row indicates significance difference (p<0.05) in mean values among different treatment periods. Different superscript numerals in the same column indicates significance difference (p<0.05) in mean values of extract. BI: Before Inoculation; AI: After Inoculation; AT: After Treatment.